IP-Backed Lending — the Non-Dilutive Option Most

Round Ready Academy — Lesson 10 of 11

Most founders, faced with a capital need, think in one dimension: equity. The options above the equity line — venture debt, revenue-based financing, IP-backed lending — are either unfamiliar or assumed to be out of reach for businesses at £1M to £10M ARR.

That assumption is increasingly out of date. UK IP-backed lending has expanded sharply since 2023. NatWest's flagship programme grew from £5M in 2024 to over £27M by early 2026, and HSBC and RBS have followed with their own growth-lending propositions anchored on intellectual property as collateral. For founders with the right asset base, IP-backed lending is a live, non-dilutive option.

This lesson covers: what qualifies as collateral, how the UK lenders are structuring the offer, how Opagio identifies qualifying assets, and worked examples.

★ Key Takeaway

IP-backed lending is not a substitute for equity. It is a complement to it. The right framing is: how much of the next £3M to £10M of capital can be non-dilutive? For companies with the right asset base, the answer is often a meaningful share — and every pound that is non-dilutive is a pound of dilution not taken.

What the UK Market Actually Looks Like

The UK IP-backed lending market in 2024-2026 is characterised by three lenders writing the bulk of identifiable cheques: NatWest (the most public programme, with a published case study library), HSBC (growth lending with IP-anchored facilities), and RBS (complementary programme at group level). A set of specialist non-bank lenders writes smaller facilities alongside.

£5M → £27M+ NatWest IP-backed programme lending volume, 2024 to early 2026

3 major UK high-street banks with active IP-backed growth lending programmes (NatWest, HSBC, RBS)

£1-10M typical facility size for UK scale-up IP-backed lending

Facility sizes range from around £1M to £10M for scale-up businesses, with larger facilities available for established companies with stronger IP portfolios. Terms are typically 3-5 years, fully amortising, with interest rates priced at a premium to secured commercial lending.

What Qualifies as Collateral

Not every intangible asset qualifies as IP-backed lending collateral. Lenders work with a tighter definition than the Opagio 12 full framework. Three categories dominate:

Qualifying Collateral — Three Categories

Category	What it includes	What it typically excludes
Registered IP	Granted patents, registered trademarks with UK/EU coverage, registered designs	Pending applications (generally insufficient alone), unregistered trademarks
Copyright and proprietary content	Documented software codebases with clear IP ownership, proprietary datasets with access and rights evidence, copyright-protected creative works	Third-party-licensed content, open-source-dependent codebases without proprietary layering
Contract-evidenced revenue streams tied to IP	Long-term licensing revenues, subscription revenue underpinned by proprietary technology, royalty streams	Consulting revenue, services revenue not tied to underlying IP

A typical qualifying portfolio at scale-up stage includes: registered trademark portfolio, granted or near-granted patents covering core technology, a documented codebase with clear chain-of-title from employees and contractors, proprietary datasets with clean data rights from customer contracts, and 24+ months of contract-backed recurring revenue.

What the Lenders Actually Assess

Bank IP-backed lending underwriting is multi-dimensional. Beyond the asset base itself, lenders typically assess four further dimensions before extending credit:

1. Clear IP ownership chain

Every piece of IP being used as collateral must have a documented chain of title. For software, this means IP assignment agreements from every engineer, founder, and contractor who contributed. For trademarks, it means clean registration history. Gaps here tend to be deal-breakers.

2. Cash flow coverage

Lenders need evidence that the business can service the debt. Minimum coverage ratios vary, but most lenders look for at least 1.5x annual free cash flow coverage on scheduled repayments. This is often the binding constraint for earlier-stage companies, even those with strong IP.

3. Independent IP valuation

Lenders typically require an independent IP valuation using one or more of the IVSC-approved methods: Relief from Royalty (RFR), Multi-Period Excess Earnings (MPEEM), or Cost Approach. The valuation establishes the collateral value and therefore the facility ceiling.

4. Covenants and monitoring

Typical covenants include quarterly reporting, IP maintenance obligations (keeping trademarks and patents renewed), restrictions on disposing of collateral IP, and financial covenants tied to revenue, cash flow, and customer retention.

How Opagio Identifies Qualifying Assets

The Opagio platform has a Lending Readiness workflow that maps your asset base against the lender qualifying criteria. The output is a Lending Readiness Report — typically 10 to 15 pages — that includes: (a) the list of qualifying collateral assets, (b) a preliminary independent valuation using the IVSC methods lenders accept, (c) a gap analysis of the covenants and documentation the lender will require, and (d) a short list of UK lenders most likely to write against your profile.

The report is not a credit decision. It is the document that allows the founder and the lender to start the conversation with an honest view of the asset base on the table.

Worked Example — A UK B2B SaaS at £3.8M ARR

This is a composite based on real patterns we see in the Opagio lending-readiness work.

Company profile: UK-based B2B SaaS, £3.8M ARR, 145 customers, average contract length 24 months, gross margin 78%. Founded 2020. Capital raised to date: £4.5M across pre-seed and seed rounds.

Qualifying asset base:

One granted UK patent covering core prediction methodology (granted Q3 2024)
Two further patent applications pending (2025 filings)
Registered trademark portfolio across UK and EU (6 marks)
Documented codebase with clean IP chain from all current and former engineers
Proprietary customer behaviour dataset, labelled, 4-year coverage

Independent valuation (RFR method, preliminary): £8.4M for the combined IP portfolio

Lending scenario: £3M facility over 4 years, secured on the IP portfolio with junior ranking after existing equity. Covenants tied to quarterly NRR remaining above 105%, quarterly gross revenue retention above 88%, and customary financial covenants.

Use of proceeds: Expansion sales hires and enterprise rollout — the same use of proceeds that would have been funded by an equity raise, at a cost of interest rather than dilution.

✔ Example

In this scenario, the £3M facility substitutes for approximately £3M of equity that would have been raised at an £18M post-money Series A. The dilution avoided is roughly 14-15% of the cap table. The total interest cost over four years is roughly £600K-£900K depending on the rate. The trade-off — £600K-£900K of interest against 14-15% of equity value — tends to favour the debt substantially in most realistic outcome scenarios.

When IP-Backed Lending Is the Wrong Answer

IP-backed lending is not always the right answer. Four situations where equity is the better instrument:

Cash flows are choppy. Debt requires predictable servicing. Businesses with lumpy or seasonal cash flows should lean toward equity.
IP portfolio is thin. If the qualifying collateral only supports a small facility, the overhead of the debt structure may not be worth it.
The capital need is for high-risk product development. Equity investors are compensated for risk. Debt investors are not. Capital funding a high-risk pivot is typically better sourced from equity.
The founder is already highly diluted and cannot afford further equity dilution. This is actually an argument for IP-backed lending, not against — it is the classic use case.

The right framing is to treat IP-backed lending as one instrument in a capital stack, not as an all-or-nothing alternative to equity. Most efficient Series B-era capital stacks blend the two.

The Right Starting Point — Two Tiers

Two tiers of the Opagio platform produce the right starting point for the IP-backed lending conversation:

The Lending Readiness Report (available as a standalone product, priced per report) is the document that identifies qualifying collateral, produces the preliminary valuation, and names the candidate lenders. This is the right starting point for founders who want to have the lending conversation without yet committing to a full platform tier.
The Pre-Seed tier (£99) is the right entry point for early-stage founders who want to start mapping their asset base ahead of a lending or capital decision. It produces the first-pass Opagio 12 profile, which sits underneath everything else in this lesson.

★ Key Takeaway

Generate a Lending Readiness Report — or start with Pre-Seed (£99) to map your asset base ahead of the lending conversation. For deeper context, see the IP-Backed Lending hub, the glossary entry on IP-Backed Lending as Collateral, and the Intangible Finance Academy. To continue this course, go to Lesson 11: Your 90-day round-ready plan.

David Stroll is Chief Scientist at Opagio. Lesson reviewed and edited by Mark Hillier, Co-Founder and CCO, drawing on the live UK IP-backed lending work. Meet the team.

Lesson 10 Quiz

Check your understanding of this lesson.

Key terms from this lesson

Not sure where to start?

Eight minutes against The Opagio 12. The diagnostic surfaces the drivers that sit above and below sector median, classifies your funded state, and routes you to the highest-relevance asset first.

Take the diagnostic →

Put this into practice

Use the Opagio Valuator to apply what you have just learned to your own business.

Try the Valuator — free

IP-Backed Lending — the Non-Dilutive Option Most Founders Never Consider